Edwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 13.6%, EPS fell 26.3%, free cash flow grew 142.8% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow EW
Edwards Lifesciences Corporation (EW) Total debt
Edwards Lifesciences Corporation's total debt at the end of fiscal 2025 was $598.3M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $598.7M. Over the past ten years it has ranged from $593.8M (fiscal 2018) to $1.0B (fiscal 2017); the current reading is higher than 82% of that period. Edwards Lifesciences Corporation ranks 28th of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $598.3M | 0.10% |
| FY2024 | $597.7M | 0.12% |
| FY2023 | $597.0M | 0.12% |
| FY2022 | $596.3M | 0.10% |
| FY2021 | $595.7M | 0.12% |
| FY2020 | $595.0M | 0.10% |
| FY2019 | $594.4M | 0.10% |
| FY2018 | $593.8M | (42.71%) |
| FY2017 | $1.0B | 26.04% |
| FY2016 | $822.3M | 37.76% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $598.7M | 0.03% |
| Mar 2026 | $598.5M | 0.03% |
| Dec 2025 | $598.3M | 0.02% |
| Sep 2025 | $598.2M | 0.03% |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| MDT Medtronic PLC compare | $28.2B |
| SYK Stryker Corporation compare | $14.9B |
| BSX Boston Scientific Corporation compare | $12.6B |
| GEHC GE HealthCare Technologies Inc. compare | $11.5B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $7.5B |
| PHG Koninklijke Philips N.V. compare | $7.3B |
| STE STERIS plc compare | $1.9B |
| DXCM DexCom, Inc. compare | $1.2B |
| EW Edwards Lifesciences Corporation | $598.7M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement